HC Wainwright & Co. reiterated coverage on BioDelivery Sciences Intl with a new price target
$BDSI
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. reiterated coverage of BioDelivery Sciences Intl with a rating of Buy and set a new price target of $6.00 from $5.50 previously